 | • レポートコード：QYR9ST03965 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、孤立性肺疾患治療の世界市場について調査・分析し、孤立性肺疾患治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（免疫抑制剤、抗炎症薬、抗線維化剤、血管拡張薬、コルチコステロイド、CFTRモジュレーター、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の孤立性肺疾患治療市場動向 ・主要企業別マーケットシェア ・孤立性肺疾患治療の種類別市場規模2014-2019 （免疫抑制剤、抗炎症薬、抗線維化剤、血管拡張薬、コルチコステロイド、CFTRモジュレーター、その他） ・孤立性肺疾患治療の用途別市場規模2014-2019 （病院薬局、小売薬局、オンライン薬局） ・孤立性肺疾患治療の北米市場：主要企業・種類別/用途別市場規模 ・孤立性肺疾患治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・孤立性肺疾患治療の中国市場：主要企業・種類別/用途別市場規模 ・孤立性肺疾患治療の日本国内市場：主要企業・種類別/用途別市場規模 ・孤立性肺疾患治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・孤立性肺疾患治療のインド市場：主要企業・種類別/用途別市場規模 ・孤立性肺疾患治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （GSK、Pfizer、Celgene、Novartis、NPS Pharmaceuticals、Auspex Pharmaceuticals、Synageva BioPharma、Roche、Sanofi） ・孤立性肺疾患治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Orphan illnesses are those which are not generally looked into, those where particular medicines are not accessible, and those which may just be of restricted enthusiasm to researchers and specialists.Orphan lung diseases are exemplified by the purported disregarded infectious diseases, which are endemic to regions mainly in Africa, Asia and the Americas.
It is to be expected that the global market of orphan lung disease treatment will show steady growth. Pharmaceutical and medical industries have gained huge profit by generating new drugs for treatment of orphan lung diseases. High number of new product and therapies are entering the market which impose can impose the growth globally.
In 2018, the global Orphan Lung Diseases Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Orphan Lung Diseases Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Orphan Lung Diseases Treatment development in United States, Europe and China.
The key players covered in this study
GSK
Pfizer
Celgene
Novartis
NPS Pharmaceuticals
Auspex Pharmaceuticals
Synageva BioPharma
Roche
Sanofi
Market segment by Type, the product can be split into
Immunosuppressants
Anti-Inflammatory Drugs
Anti-Fibrotic Agents
Vasodilators
Corticosteroids
CFTR Modulators
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Orphan Lung Diseases Treatment status, future forecast, growth opportunity, key market and key players.
To present the Orphan Lung Diseases Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Orphan Lung Diseases Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Orphan Lung Diseases Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Immunosuppressants
1.4.3 Anti-Inflammatory Drugs
1.4.4 Anti-Fibrotic Agents
1.4.5 Vasodilators
1.4.6 Corticosteroids
1.4.7 CFTR Modulators
1.4.8 Others
1.5 Market by Application
1.5.1 Global Orphan Lung Diseases Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Orphan Lung Diseases Treatment Market Size
2.2 Orphan Lung Diseases Treatment Growth Trends by Regions
2.2.1 Orphan Lung Diseases Treatment Market Size by Regions (2014-2025)
2.2.2 Orphan Lung Diseases Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Orphan Lung Diseases Treatment Market Size by Manufacturers
3.1.1 Global Orphan Lung Diseases Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Orphan Lung Diseases Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Orphan Lung Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Orphan Lung Diseases Treatment Key Players Head office and Area Served
3.3 Key Players Orphan Lung Diseases Treatment Product/Solution/Service
3.4 Date of Enter into Orphan Lung Diseases Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Orphan Lung Diseases Treatment Market Size by Type (2014-2019)
4.2 Global Orphan Lung Diseases Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Orphan Lung Diseases Treatment Market Size (2014-2019)
5.2 Orphan Lung Diseases Treatment Key Players in United States
5.3 United States Orphan Lung Diseases Treatment Market Size by Type
5.4 United States Orphan Lung Diseases Treatment Market Size by Application
6 Europe
6.1 Europe Orphan Lung Diseases Treatment Market Size (2014-2019)
6.2 Orphan Lung Diseases Treatment Key Players in Europe
6.3 Europe Orphan Lung Diseases Treatment Market Size by Type
6.4 Europe Orphan Lung Diseases Treatment Market Size by Application
7 China
7.1 China Orphan Lung Diseases Treatment Market Size (2014-2019)
7.2 Orphan Lung Diseases Treatment Key Players in China
7.3 China Orphan Lung Diseases Treatment Market Size by Type
7.4 China Orphan Lung Diseases Treatment Market Size by Application
8 Japan
8.1 Japan Orphan Lung Diseases Treatment Market Size (2014-2019)
8.2 Orphan Lung Diseases Treatment Key Players in Japan
8.3 Japan Orphan Lung Diseases Treatment Market Size by Type
8.4 Japan Orphan Lung Diseases Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Orphan Lung Diseases Treatment Market Size (2014-2019)
9.2 Orphan Lung Diseases Treatment Key Players in Southeast Asia
9.3 Southeast Asia Orphan Lung Diseases Treatment Market Size by Type
9.4 Southeast Asia Orphan Lung Diseases Treatment Market Size by Application
10 India
10.1 India Orphan Lung Diseases Treatment Market Size (2014-2019)
10.2 Orphan Lung Diseases Treatment Key Players in India
10.3 India Orphan Lung Diseases Treatment Market Size by Type
10.4 India Orphan Lung Diseases Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Orphan Lung Diseases Treatment Market Size (2014-2019)
11.2 Orphan Lung Diseases Treatment Key Players in Central & South America
11.3 Central & South America Orphan Lung Diseases Treatment Market Size by Type
11.4 Central & South America Orphan Lung Diseases Treatment Market Size by Application
12 International Players Profiles
12.1 GSK
12.1.1 GSK Company Details
12.1.2 Company Description and Business Overview
12.1.3 Orphan Lung Diseases Treatment Introduction
12.1.4 GSK Revenue in Orphan Lung Diseases Treatment Business (2014-2019)
12.1.5 GSK Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Orphan Lung Diseases Treatment Introduction
12.2.4 Pfizer Revenue in Orphan Lung Diseases Treatment Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Celgene
12.3.1 Celgene Company Details
12.3.2 Company Description and Business Overview
12.3.3 Orphan Lung Diseases Treatment Introduction
12.3.4 Celgene Revenue in Orphan Lung Diseases Treatment Business (2014-2019)
12.3.5 Celgene Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Orphan Lung Diseases Treatment Introduction
12.4.4 Novartis Revenue in Orphan Lung Diseases Treatment Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 NPS Pharmaceuticals
12.5.1 NPS Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Orphan Lung Diseases Treatment Introduction
12.5.4 NPS Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2014-2019)
12.5.5 NPS Pharmaceuticals Recent Development
12.6 Auspex Pharmaceuticals
12.6.1 Auspex Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Orphan Lung Diseases Treatment Introduction
12.6.4 Auspex Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2014-2019)
12.6.5 Auspex Pharmaceuticals Recent Development
12.7 Synageva BioPharma
12.7.1 Synageva BioPharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Orphan Lung Diseases Treatment Introduction
12.7.4 Synageva BioPharma Revenue in Orphan Lung Diseases Treatment Business (2014-2019)
12.7.5 Synageva BioPharma Recent Development
12.8 Roche
12.8.1 Roche Company Details
12.8.2 Company Description and Business Overview
12.8.3 Orphan Lung Diseases Treatment Introduction
12.8.4 Roche Revenue in Orphan Lung Diseases Treatment Business (2014-2019)
12.8.5 Roche Recent Development
12.9 Sanofi
12.9.1 Sanofi Company Details
12.9.2 Company Description and Business Overview
12.9.3 Orphan Lung Diseases Treatment Introduction
12.9.4 Sanofi Revenue in Orphan Lung Diseases Treatment Business (2014-2019)
12.9.5 Sanofi Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Orphan Lung Diseases Treatment Key Market Segments
Table Key Players Orphan Lung Diseases Treatment Covered
Table Global Orphan Lung Diseases Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Orphan Lung Diseases Treatment Market Size Market Share by Type 2014-2025
Figure Immunosuppressants Figures
Table Key Players of Immunosuppressants
Figure Anti-Inflammatory Drugs Figures
Table Key Players of Anti-Inflammatory Drugs
Figure Anti-Fibrotic Agents Figures
Table Key Players of Anti-Fibrotic Agents
Figure Vasodilators Figures
Table Key Players of Vasodilators
Figure Corticosteroids Figures
Table Key Players of Corticosteroids
Figure CFTR Modulators Figures
Table Key Players of CFTR Modulators
Figure Others Figures
Table Key Players of Others
Table Global Orphan Lung Diseases Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Orphan Lung Diseases Treatment Report Years Considered
Table Global Orphan Lung Diseases Treatment Market Size 2014-2025 (Million US$)
Figure Global Orphan Lung Diseases Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Orphan Lung Diseases Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Orphan Lung Diseases Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Orphan Lung Diseases Treatment Market Share by Regions 2014-2019
Figure Global Orphan Lung Diseases Treatment Market Share by Regions 2014-2019
Figure Global Orphan Lung Diseases Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Orphan Lung Diseases Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Orphan Lung Diseases Treatment Market Share by Manufacturers (2014-2019)
Figure Global Orphan Lung Diseases Treatment Market Share by Manufacturers in 2018
Table Global Orphan Lung Diseases Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Orphan Lung Diseases Treatment Product/Solution/Service
Table Date of Enter into Orphan Lung Diseases Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Orphan Lung Diseases Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Orphan Lung Diseases Treatment Market Size Share by Type (2014-2019)
Figure Global Orphan Lung Diseases Treatment Market Size Market Share by Type (2014-2019)
Table Global Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Orphan Lung Diseases Treatment Market Size Share by Application (2014-2019)
Figure Global Orphan Lung Diseases Treatment Market Size Market Share by Application (2014-2019)
Figure Global Orphan Lung Diseases Treatment Revenue Market Share by Application in 2018
Figure United States Orphan Lung Diseases Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Orphan Lung Diseases Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Orphan Lung Diseases Treatment Market Share (2018-2019)
Table United States Orphan Lung Diseases Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Orphan Lung Diseases Treatment Market Share by Type (2014-2019)
Table United States Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Orphan Lung Diseases Treatment Market Share by Application (2014-2019)
Figure Europe Orphan Lung Diseases Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Orphan Lung Diseases Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Orphan Lung Diseases Treatment Market Share (2018-2019)
Table Europe Orphan Lung Diseases Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Orphan Lung Diseases Treatment Market Share by Type (2014-2019)
Table Europe Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Orphan Lung Diseases Treatment Market Share by Application (2014-2019)
Figure China Orphan Lung Diseases Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Orphan Lung Diseases Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Orphan Lung Diseases Treatment Market Share (2018-2019)
Table China Orphan Lung Diseases Treatment Market Size by Type (2014-20189) (Million US$)
Table China Orphan Lung Diseases Treatment Market Share by Type (2014-2019)
Table China Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table China Orphan Lung Diseases Treatment Market Share by Application (2014-2019)
Figure Japan Orphan Lung Diseases Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Orphan Lung Diseases Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Orphan Lung Diseases Treatment Market Share (2018-2019)
Table Japan Orphan Lung Diseases Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Orphan Lung Diseases Treatment Market Share by Type (2014-2019)
Table Japan Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Orphan Lung Diseases Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Orphan Lung Diseases Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Orphan Lung Diseases Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Orphan Lung Diseases Treatment Market Share (2018-2019)
Table Southeast Asia Orphan Lung Diseases Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Orphan Lung Diseases Treatment Market Share by Type (2014-2019)
Table Southeast Asia Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Orphan Lung Diseases Treatment Market Share by Application (2014-2019)
Figure India Orphan Lung Diseases Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Orphan Lung Diseases Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Orphan Lung Diseases Treatment Market Share (2018-2019)
Table India Orphan Lung Diseases Treatment Market Size by Type (2014-2019) (Million US$)
Table India Orphan Lung Diseases Treatment Market Share by Type (2014-2019)
Table India Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table India Orphan Lung Diseases Treatment Market Share by Application (2014-2019)
Figure Central & South America Orphan Lung Diseases Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Orphan Lung Diseases Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Orphan Lung Diseases Treatment Market Share (2018-2019)
Table Central & South America Orphan Lung Diseases Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Orphan Lung Diseases Treatment Market Share by Type (2014-2019)
Table Central & South America Orphan Lung Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Orphan Lung Diseases Treatment Market Share by Application (2014-2019)
Table GSK Company Details
Table GSK Revenue in Orphan Lung Diseases Treatment Business (2014-2019) (Million US$)
Figure GSK Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019)
Table GSK Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Celgene Company Details
Table Celgene Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019)
Table Celgene Recent Development
Table Novartis Company Details
Table Novartis Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019)
Table Novartis Recent Development
Table NPS Pharmaceuticals Company Details
Table NPS Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$)
Figure NPS Pharmaceuticals Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019)
Table NPS Pharmaceuticals Recent Development
Table Auspex Pharmaceuticals Company Details
Table Auspex Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$)
Figure Auspex Pharmaceuticals Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019)
Table Auspex Pharmaceuticals Recent Development
Table Synageva BioPharma Company Details
Table Synageva BioPharma Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$)
Figure Synageva BioPharma Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019)
Table Synageva BioPharma Recent Development
Table Roche Company Details
Table Roche Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019)
Table Roche Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Orphan Lung Diseases Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Global Orphan Lung Diseases Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Orphan Lung Diseases Treatment Market Size Share by Regions (2019-2025)
Figure Global Orphan Lung Diseases Treatment Market Size Share by Regions in 2025
Figure United States Orphan Lung Diseases Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Orphan Lung Diseases Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Orphan Lung Diseases Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Orphan Lung Diseases Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Orphan Lung Diseases Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Orphan Lung Diseases Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Orphan Lung Diseases Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Orphan Lung Diseases Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Orphan Lung Diseases Treatment Market Size by Product (2019-2025)
Figure Global Orphan Lung Diseases Treatment Market Size by Product in 2025
Table Global Orphan Lung Diseases Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Orphan Lung Diseases Treatment Market Size by Application (2019-2025)
Figure Global Orphan Lung Diseases Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
慢性肺疾患治療の世界市場：市場規模・現状・予測 Lung disease is a very common medical condition that is present in almost every region of the world. Chronic lung diseases can be dangerous and if not treated properly can cause death. The chronic lung diseases cause uneasiness and complications in the respiratory system thus causing difficulty in r…- 後天的孤児血液疾患治療薬の世界市場：市場規模・現状・予測 Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the blood. This disease is characterized by the body’s inability to produce red blood cells. Moreover, improper functioning of bone marrow also leads to lack …
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …
- 免疫介在性炎症性疾患治療の世界市場：市場規模・現状・予測 Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune respon…